Ruthenium-97 hepatobiliary agents for delayed studies of the biliary tract. I. ru-97 PIPIDA: concise communication.
Emma R. Schachner, Peter Richards(Analytical Services), Josep M. Badía(Hospital General de Granollers), S.C. Srivastava(Chhatrapati Shahu Ji Maharaj University), Ralph G. Fairchild, P. Som(Brookhaven National Laboratory), Harold Atkins(University of Ottawa), M. C. Gil, D.F. Sacker(Brookhaven National Laboratory)
PubMed
April 1, 1981
Cited by 22
Related Papers
VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents
|Cancer Cell|2003|850
Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus
|Nature Medicine|2000|816
A FLUORINATED GLUCOSE ANALOG, 2-FLUORO-2-DEOXY-D-GLUCOSE (F-18)
|Journal of Computer Assisted Tomography|1980|503
Glucose Metabolic Rate Kinetic Model Parameter Determination in Humans: The Lumped Constants and Rate Constants for [ <sup>18</sup> F]Fluorodeoxyglucose and [ <sup>11</sup> C]Deoxyglucose
|Journal of Cerebral Blood Flow & Metabolism|1985|419